Your browser doesn't support javascript.
loading
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5.
Rothenberg, Marc E; Roufosse, Florence; Faguer, Stanislas; Gleich, Gerald J; Steinfeld, Jonathan; Yancey, Steven W; Mavropoulou, Eleni; Kwon, Namhee.
Afiliação
  • Rothenberg ME; Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
  • Roufosse F; Department of Internal Medicine, Erasmus Hospital, Free University of Brussels, Brussels, Belgium.
  • Faguer S; Department of Nephrology and Organ Transplantation, Reference Center for Rare Kidney Diseases, Rangueil Hospital, Toulouse University Hospital, Toulouse, France.
  • Gleich GJ; Departments of Dermatology and Medicine, School of Medicine, University of Utah, Salt Lake City, Utah.
  • Steinfeld J; Respiratory Research & Development, GSK, Collegeville, Pa.
  • Yancey SW; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC.
  • Mavropoulou E; Clinical Statistics, GSK, Uxbridge, Middlesex, UK.
  • Kwon N; Respiratory Research & Development, GSK, Brentford, Middlesex, UK. Electronic address: namhee.n.kwon@gsk.com.
J Allergy Clin Immunol Pract ; 10(9): 2367-2374.e3, 2022 09.
Article em En | MEDLINE | ID: mdl-35568330
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-5 / Síndrome Hipereosinofílica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-5 / Síndrome Hipereosinofílica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article